{
  "id": 16276374,
  "title": "Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma",
  "url": "https://urgent.news/2026/10/24/junshi-biosciences-announces-completion-of-first-patient-dosing-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-24T03:34:18.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/junshi-biosciences-announces-completion-of-first-patient-dosing-in-the-phase-3-clinical-trial-of-js203-in-combination-with-chemotherapy-for-the-treatment-of-diffuse-large-b-cell-lymphoma"
  },
  "original_language": "en",
  "account": null,
  "summary": "SHANGHAI, China, Oct. 23, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the first patient dosing has been completed in a randomized, open-label, multicenter phase 3 clinical study of…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Bristol Myers reveals autoimmune CAR-T trial death, explains summertime pause",
        "url": "https://urgent.news/2026/10/23/bristol-myers-reveals-autoimmune-car-t-trial-death-explains",
        "published": "2026-10-23T14:33:54.000Z"
      },
      {
        "outlet": "STAT News",
        "title": "STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial",
        "url": "https://urgent.news/2026/10/23/stat-patient-dies-in-bristol-myers-squibb-autoimmune-car-t-trial",
        "published": "2026-10-23T18:55:12.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}